Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares were up 3.5% during mid-day trading on Friday . The stock traded as high as GBX 6.60 ($0.09) and last traded at GBX 6.60 ($0.09). Approximately 607 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 264,952 shares. The stock had previously closed at GBX 6.38 ($0.08).
Ondine Biomedical Stock Up 3.5 %
The business’s 50 day moving average is GBX 7.59 and its 200-day moving average is GBX 7.77. The stock has a market cap of £18.30 million, a price-to-earnings ratio of -165.00 and a beta of 0.10. The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Stories
- Five stocks we like better than Ondine Biomedical
- Health Care Stocks Explained: Why You Might Want to Invest
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- What Are Dividend Challengers?
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- Stock Splits, Do They Really Impact Investors?
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
